Skip to main content
. 2022 Jul 13;16(2):450–458. doi: 10.1007/s40617-022-00730-8

Fig. 1.

Fig. 1

Daily Buprenorphine Adherence for All Participants over 12 Weeks. Note. Each row shows outcomes from an individual participant, with each square representing one day of a participant’s expected treatment. Dark shaded squares indicate days in which buprenorphine adherence was directly confirmed via GPS or video. Vertical lines indicate weeks. Horizontal lines indicate mean days of confirmed adherence per participant in each week, across all participants